ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Radiopharm Theranostics Limited

Radiopharm Theranostics Limited (RAD)

0.027
0.0005
(1.89%)
Closed January 27 11:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.027
Bid
0.027
Ask
0.029
Volume
18,018,228
0.026 Day's Range 0.028
0.022 52 Week Range 0.085
Market Cap
Previous Close
0.0265
Open
0.026
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,230,709
Shares Outstanding
451,795,622
Dividend Yield
-
PE Ratio
-0.28
Earnings Per Share (EPS)
-0.11
Revenue
1.96M
Net Profit
-47.95M

About Radiopharm Theranostics Limited

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Headquarters
Melbourne, Victoria, Aus
Founded
-
Radiopharm Theranostics Limited is listed in the In Vitro,in Vivo Diagnostics sector of the Australian Stock Exchange with ticker RAD. The last closing price for Radiopharm Theranostics was AUD0.03. Over the last year, Radiopharm Theranostics shares have traded in a share price range of AUD 0.022 to AUD 0.085.

Radiopharm Theranostics currently has 451,795,622 shares outstanding. The market capitalization of Radiopharm Theranostics is AUD11.97 million. Radiopharm Theranostics has a price to earnings ratio (PE ratio) of -0.28.

RAD Latest News

Consolidated Summary Of September Retail Sales Results

The following companies are among those that have reported September retail sales: COMPANY SYMBOL SAME-STORE S-S ESTIMATE Abercrombie & Fitch ANF (18.0%) (21.0%) Aeropostale ARO 19.0% 12.4...

Report: US Pharmacy Revenues To Surpass $350 Billion By 2015

By Dinah Wisenberg Brin Of DOW JONES NEWSWIRES U.S. pharmacies should generate more than $350 billion in prescription-drug revenue by 2015, an increase of some $100 billion from last year, with...

US EQUITIES WEEK AHEAD: Fed Meeting; World Leaders At UN, G20

The Federal Reserve could signal an exit strategy from the U.S. policy of monetary easing when it meets next week, according to analysts. Government reports are likely to show sales of new and...

Drug Stores Poised To Benefit From Potential H1N1 Resurgence

Drug stores are poised to benefit should a second wave of the H1N1 virus emerge in the U.S. How much the country's three largest drug chains, Walgreen Co. (WAG), Rite Aid Corp. (RAD) and CVS...

Consolidated Summary of August Retail Sales Results

The following companies are among those that have reported August retail sales: COMPANY SYMBOL SAME-STORE S-S ESTIMATE Abercrombie & Fitch ANF (29.0%) (23.9%) Aeropostale ARO 9.0% 7.1...

Consolidated Summary of July Retail Sales Results

The following companies are among those that have reported July retail sales: Company SYMBOL SAME-STORE S-S ESTIMATE Abercrombie & Fitch ANF (28.0%) (26.9%) Aeropostale ARO 6.0% 9.8...

Consolidated Summary Of June Retail Sales Results

The following companies are among those that have reported June retail sales: COMPANY SYMBOL SAME-STORE S-S ESTIMATE Abercrombie & Fitch ANF (32.0%) (28.2%) Aeropostale ARO 12.0% 10.2...

Consolidated Summary Of June Retail Sales Results

The following companies are among those that have reported June retail sales: COMPANY SYMBOL SAME-STORE S-S ESTIMATE Hot Topic HOTT (7.9%) (6.4%) Rite Aid RAD (0.6%) 1.4% Walgreen WAG 3.4% a...

UPDATE:DOJ Changes Policy On Pharma Pacts That Delay Generics

The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of generic drugs, the latest change in antitrust...

DOJ Changes Policy On Pharma Settlements That Delay Generics

The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent settlements that delay the introduction of generic drugs, the latest change in antitrust...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.002-6.896551724140.0290.030.02688950940.02730975DE
40.00280.0250.0380.023116814590.03007962DE
120.00280.0250.0420.02292307090.03061838DE
26-0.014-34.14634146340.0410.0420.02270408510.03054764DE
52-0.056-67.46987951810.0830.0850.02242042920.03252466DE
156-0.343-92.70270270270.370.3750.02216627190.0512227DE
260-0.443-94.25531914890.470.4950.02216970220.07326391DE

RAD - Frequently Asked Questions (FAQ)

What is the current Radiopharm Theranostics share price?
The current share price of Radiopharm Theranostics is AUD 0.027
How many Radiopharm Theranostics shares are in issue?
Radiopharm Theranostics has 451,795,622 shares in issue
What is the market cap of Radiopharm Theranostics?
The market capitalisation of Radiopharm Theranostics is AUD 11.97M
What is the 1 year trading range for Radiopharm Theranostics share price?
Radiopharm Theranostics has traded in the range of AUD 0.022 to AUD 0.085 during the past year
What is the PE ratio of Radiopharm Theranostics?
The price to earnings ratio of Radiopharm Theranostics is -0.28
What is the cash to sales ratio of Radiopharm Theranostics?
The cash to sales ratio of Radiopharm Theranostics is 6.98
What is the reporting currency for Radiopharm Theranostics?
Radiopharm Theranostics reports financial results in AUD
What is the latest annual turnover for Radiopharm Theranostics?
The latest annual turnover of Radiopharm Theranostics is AUD 1.96M
What is the latest annual profit for Radiopharm Theranostics?
The latest annual profit of Radiopharm Theranostics is AUD -47.95M
What is the registered address of Radiopharm Theranostics?
The registered address for Radiopharm Theranostics is LEVEL 3, 62 LYGON STREET, CARLTON, MELBOURNE, VICTORIA, 3053
What is the Radiopharm Theranostics website address?
The website address for Radiopharm Theranostics is www.radiopharmtheranostics.com
Which industry sector does Radiopharm Theranostics operate in?
Radiopharm Theranostics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CDXOACardieX Limited
AUD 0.03
(76.47%)
2.19M
AQNAquirian Limited
AUD 0.295
(63.89%)
1.08M
CUFOCuFe Ltd
AUD 0.003
(50.00%)
301k
AQDAusquest Limited
AUD 0.033
(50.00%)
54.32M
LYNLycaon Resources Ltd
AUD 0.245
(48.48%)
642.61k
RADORadiopharm Theranostics Ltd
AUD 0.002
(-50.00%)
327.64k
RPMORPM Automotive Group Limited
AUD 0.002
(-50.00%)
2.21M
NHEONoble Helium Ltd
AUD 0.001
(-50.00%)
20k
PRSOAProspech Limited
AUD 0.001
(-50.00%)
66.67k
HFYHubify Limited
AUD 0.007
(-36.36%)
13.82M
ATHOAlterity Therapeutics Limited
AUD 0.004
(0.00%)
86.56M
AQDAusquest Limited
AUD 0.033
(50.00%)
54.32M
SYASayona Mining Limited
AUD 0.023
(-4.17%)
41.31M
BTRBrightstar Resources Limited
AUD 0.021
(0.00%)
36.06M
TMKTMK Energy Ltd
AUD 0.0025
(0.00%)
32.33M

Discussion

View Full Feed
dinogreeves dinogreeves 5 minutes ago
This is shaking the market

https://www.yahoo.com/finance/news/nasdaq-futures-slump-china-deepseek-022904517.html
SMCI
StockItOut StockItOut 7 minutes ago
What a bunch of pure Quester bullshit: Your stupid AI questions.

There are no "pro-rate shares" like your conjure.

Get a dictionary. Look-up pro-rata.

Check out XTI's 10-K: Although Xeriant did not make the full Intended Contribution, it is entitled to re
XERI
hbhmb hbhmb 11 minutes ago
What is with the name calling you guys resort to when you disagree with someone you all sound like 2 nd graders sheesh
AIAD
boston127 boston127 12 minutes ago
NVNI is in a strong bullish trend.

Its 200-day moving average is upwards sloping and the MACD histogram is above 0 and rising. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.
NVNI
robinandthe7hoods robinandthe7hoods 12 minutes ago
What has to be remembered is that Verses AI isn't even out of its beta phase yet.
Anybody name another o/s or any other tech that made a big splash before it was even out of beta testing?
VRSSF
Investor082 Investor082 17 minutes ago
It’s not a question of whether BP can afford it. They throw so much money on companies they are strategically interested in partnering. NWBO is just not one of them. And there are quite of these companies like NWBO as well.
NWBO
Steady_T Steady_T 17 minutes ago
I was unaware that he made that comment in reference to the EMA. I remember that in conjunction with discussion of the FDA.
My bad.
AVXL
Oleblue Oleblue 19 minutes ago
Initially celebrated for its groundbreaking speed and unmatched computational power, Willow suddenly became the center of mystery, speculation, and fear. Sources claim that scientists spotted something strange in its final data streams - anomalies that defied explanation. Then, an ethical hacker unc
GOOG
ramfan60 ramfan60 25 minutes ago
Well Nukem..... Allen did his part for Buffalo to win..... the receiver dropped a ball right in his hands on that last 4th down drive. Some questionable play calls as well from the Bills coach didn't help....... don't run Allen right into the meat of of KC line.....spread them out and let Allen run
AMRN
StockItOut StockItOut 29 minutes ago
He's pre-decided the end-story of his scam story, so then everything Xeriant does is a scam (except he wants Xeriant to play legit with an 8-K about XTI issued shares that were auto cancelled and turned into XTIA shares that he is too stupid to understand) so he fabricates to try to make it fit his
XTIA
StockItOut StockItOut 29 minutes ago
of course they own it. If not, who owns the shares issued to Xeriant?

Your claim never gets explained.

You're afraid your conclusion will unravel your fabricated story.
XERI
shajandr shajandr 32 minutes ago
https://www.spiked-online.com/2024/12/31/what-really-happened-in-wuhan/
along4zride along4zride 37 minutes ago
Last seen heading south . (FNMA)
PPS. 
Forecast : 
Monday $5.45
Tuesday $ 5.09
Wednesday $ 4.95
Thursday $ 5.01
Friday $ 4.72
FNMA
XMaster2023 XMaster2023 39 minutes ago
Investor082; As a paid poster, do you really believe BP can not afford to run a trial with NWBO? You have seen the preliminary results with Keytruda? The answer to this question is NO! Post approval, BP will become NWBO best friend.
NWBO
Zorax Zorax 40 minutes ago
Okay, now a military coup is looking so much more reasonable.
BDEZ BDEZ 40 minutes ago
Agree...
Researchfyi Researchfyi 42 minutes ago
Can’t change history, it was what it was. The present, is what it is and I can’t guarantee the future, it is what it will be.
That covers 3 through 4. # 1, is subjective.

In essence the year after seems to be a carbon copy of the year before no matter who is operating the comp
LQMT
D-Mart D-Mart 44 minutes ago
The screen as well. I didn’t mention it because LQMT doesn’t solve that problem. From what I’ve recently read it’s a heavy dose of both needing to be solved. For me personally I don’t get the appeal. The phone is smaller length and width in your pocket, but twice as thick? Seems like a gimmick. But
LQMT
ducci1 ducci1 44 minutes ago
Looked at U trade---Pivot stalled U trade 1/2 way down to the 5 min Red Line--thats all U could do!--Allways problematic when Pivot ridin above Da 5 min Red Line ! Just have to take the Scalp !! ( U Target was the 5 min Red Line Magnet---Yes ? )
SPY

Your Recent History

Delayed Upgrade Clock